Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 5, 2008, Pages 1062-1065

  Peeters, Elke ^a   Nelis, Hans J ^a   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Cystic fibrosis; Infection; Iron metabolism; Pseudomonas aeruginosa

Indexed keywords

GALLIUM; IRON; RESAZURIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOFILM; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MULTIVORANS; CELL VIABILITY; CONTROLLED STUDY; CYSTIC FIBROSIS; DILUTION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PSEUDOMONAS AERUGINOSA;

BACTERIOLOGICAL TECHNIQUES; BIOFILMS; BURKHOLDERIA CEPACIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; GALLIUM; MICROBIAL SENSITIVITY TESTS;

EID: 42149127657     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn072     Document Type: Article

References (10)

1. Burns J. Antibiotic resistance of Burkholderia spp. In: Coenye T, Vandamme P, eds. Burkholderia: Molecular Biology and Genomics. Wymondham: Horizon Press, 2007; 81-91.
2. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-8.
3. Caraher E, Reynolds G, Murphy P et al. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis 2007; 26: 213-6.
4. Kaneko Y, Thoendel M, Olakanmi O et al. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 2007; 117 877-88.
5. European Committee for Antimicrobial Susceptibility Testing (EUCAST). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect 2003; 9: Ix-xv.
6. McKenney D, Allison DG. Effects of growth rate and nutrient limitation on virulence factor production in Burkholderia cepacia. J Bacteriol 1995; 177: 4140-3.
7. Reid DW, Withers NJ, Francis L et al. Iron deficiency in cystic fibrosis: Relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 2002; 121: 48-54.
8. Harrington JR, Martens RJ, Cohen ND et al. Antimicrobial activity of gallium against virulent Rhodocoocus equi in vitro and in vivo. J Vet Pharmacol Ther 2006; 29: 121-7.
9. Olakanmi O, Britigan BE, Schlesinger LS. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect Immun 2000; 68: 5619-27.
10. Bernstein LR. Mechanisms of therapeutic activity for gallium. Pharmcol Rev 1998; 50: 665-82.